Registration - Amendment

NVG, LLC for BIOVENTUS, LLC

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reclassification of certain DME products from routinely purchased to capped rental, and guidance on grandfathered products under the 3 year minimum lifetime requirement for DME in the CMS proposed rule on the annual update to the End-Stage Renal Disease (ESRD) Prospective Payment System.

LobbyistCovered position, as disclosed
ABBY LYNNE BOWNAS New Legislative Correspondent, Senator Harry Reid ; ; Executive Aide/Scheduler/Office Manager, ; ; Legislative Assistant, Congressman John Tierney
IRENE BUENO New Legis. Asst., Cong. Roybal ; ; Legis. Asst., Sen. Cranston ; ; Spec. Asst. to Asst. Secy for Legislation, HHS ; ; Dep. Asst. Secy for for Legislation, HHS ; ; Spec. Asst. to the President, White House
LISA GERMAN FOSTER New Senior Policy Advisor, Senator Jack Reed
JANE LOEWENSON New Health Fellow, Senator George Mitchell, Professional Staff ; ; Member, Subcommittee on Children and Families of the Senate ; ; and Labor and Human Resources Comte., Sen. Chris Dodd ; ; Senior Health Policy Advisor, Senator Thomas A. Daschle

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
SMITH & NEPHEW (OVERSEAS) LIMITED (BY INDIRECT OWNERSHIP) United Kingdom United Kingdom 4.0% —
SMITH & NEPHEW (EUROPE) B.V. Netherlands Netherlands 49.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.